Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Indivior ( (INDV) ).
Indivior PLC announced that Juliet Thompson, a Non-Executive Director, and Timothy Thompson, a person closely associated with her, each purchased 1,925 ordinary shares of the company at $13.88 per share. These transactions were part of the NED Share Program, which was implemented under the Directors’ Remuneration Policy approved at the 2025 Annual General Meeting. This acquisition reflects the confidence of the company’s leadership in its strategic direction and market position.
More about Indivior
Indivior PLC is a pharmaceutical company that specializes in the development and marketing of medications for the treatment of addiction and other mental health disorders. The company focuses on providing innovative solutions to address the needs of patients with substance use disorders.
See more data about INDV stock on TipRanks’ Stock Analysis page.